Nu Skin Enterprises, Toyo Bio-Pharma Team On Product Research, Development

Trading Markets

Nu Skin Enterprises, Inc. has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc., a natural products manufacturer with facilities in the United States and Japan.

To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States.

Nu Skin Enterprises said it is the first direct selling company to have such an agreement with Toyo Bio-Pharma. The companies' collaborative development efforts will focus on sharing scientific and regulatory insights, as well as developing proprietary nutraceutical and cosmeceutical products for Nu Skin sales through its worldwide distribution network.

Japan-based Toyo Bio-Pharma is a subsidiary of Toyo Shinyaku Co., a manufacturer focused on providing consumers and clients with ingredients derived from nature.